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Androgens are essential for the normal function ofmature antral follicles but also have a role in the
early stages of follicle development. Polycystic ovary syndrome (PCOS), the most common cause of
anovulatory infertility, is characterized by androgen excess and aberrant follicle development that
includes accelerated early follicle growth. We have examined the effects of testosterone and
dihydrotestosterone (DHT) on development of isolated mouse preantral follicles in culture with the
specific aim of investigating interaction with follicle-stimulating hormone (FSH), the steroidogenic
pathway, and growth factors of the TGFb superfamily that are known to have a role in early follicle
development. Both testosterone and DHT stimulated follicle growth and augmented FSH-induced
growth and increased the incidence of antrum formation among the granulosa cell layers of these
preantral follicles after 72 hours in culture. Effects of both androgens were reversed by the androgen
receptor antagonist flutamide. FSH receptor expression was increased in response to both testos-
terone and DHT, as was that of Star, whereas Cyp11a1 was down-regulated. The key androgen-
induced changes in the TGFb signaling pathway were down-regulation of Amh, Bmp15, and their
receptors. Inhibition of Alk6 (Bmpr1b), a putative partner for Amhr2 and Bmpr2, by dorsomorphin
resulted in augmentation of androgen-stimulated growth and modification of androgen-induced
gene expression. Our findings point to varied effects of androgen on preantral follicle growth and
function, including interaction with FSH-activated growth and steroidogenesis, and, importantly,
implicate the intrafollicular TGFb systemas a keymediator of androgenaction. These findings provide
insight into abnormal early follicle development in PCOS. (Endocrinology 158: 920–935, 2017)
It has long been recognized that androgens have aphysiological role in normal ovarian function. Andro-
gens provide an obligatory substrate for estradiol pro-
duction by maturing antral follicles [and may enhance
either basal or follicle-stimulating hormone (FSH)–induced
steroidogenesis by isolated granulosa cells (GCs)] (1–4),
but there is also evidence that androgens may be neces-
sary for the earliest stages of ovarian follicle development.
Mice lacking a functional androgen receptor (AR) have
impaired fertility (reduced litter size and/or reduced
reproductive lifespan) but also show impaired growth and
enhanced atresia of preantral follicles (5–7). Both aroma-
tizable and nonaromatizable androgens have been shown
to stimulate growth of isolatedmouse preantral follicles (1)
and effect activation of follicle development in fragments
of bovine ovarian cortex (8, 9).
Exposure to excess androgen, however, is associated
with ovarian dysfunction. In experimental animals, an-
drogens inhibit proliferation (10) and increase apoptosis
(11) in GCs frommature rat follicles. Importantly, ovarian
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dysfunction is a major feature of women with polycystic
ovary syndrome (PCOS), a very common endocrine dis-
order in which ovarian hyperandrogenism is the key bio-
chemical feature (12, 13). Infrequent or absent ovulation is
characteristic, and this is associated with arrest of antral
follicles during the final stages of maturation (14). How-
ever, anovulation in PCOS is also associated with aberrant
development of preantral follicles, the key features of which
are increased activation of follicle growth from the pri-
mordial stage (15) and enhanced GC proliferation in small
preantral follicles (16) coupled with apparent “stockpiling”
of follicles at the primary stage (17). Thus, ovarian dys-
function in PCOS would seem to have its origins at the
earliest stages of follicle development at a point when,
under physiological conditions, gonadotropin action is not
obligatory and local growth factors are likely to play an
important role. Furthermore, the abnormalities observed
in preantral follicle development are characterized by en-
hanced rather than impaired activation and growth, and
there is evidence that androgens may play a part.
The prenatally androgenized (PA) sheep is a well-
established large animal model of PCOS. Lambs born to
ewes that have been exposed during pregnancy to large
doses of exogenous testosterone or dihydrotestosterone
(DHT) have both reproductive and metabolic abnormalities
that are reminiscent of PCOS (18, 19). Critically, ovarian
dysfunction includes not only evidence of disrupted neuro-
endocrine control of the ovulation cycle but also abnormal
preantral follicle development. In particular, the pattern of
early follicle development in the ovaries of the PA sheep
mirrors that observed in ovarian tissue from women with
PCOS; theproportionof growing follicles is increased, and the
primordial folliclepopulation reciprocallydiminished inovary
cortex from PA compared with control animals (20, 21).
We have previously used isolated mouse preantral fol-
licles in culture to examine the direct effects, on early de-
veloping follicles, of growth factors on follicle growth, GC
proliferation and gene expression (22, 23). Here we have
applied this methodology to the investigation of the effects of
androgens with the specific aims of investigating the in-
teraction of androgens with FSH and with growth factors of
theTGFb superfamily.Thesegrowth factorshaveakey role in
ovarian follicular function, and our previous studies of iso-
lated mouse preantral follicles have provided evidence for the
involvement of both inhibitory and stimulatory TGFb mol-
ecules (and their endogenous inhibitors and binding proteins)
in growth and function of small preantral follicles (22, 23).
Material and Methods
Tissue collection, follicle isolation, and culture
Whole ovaries were collected from C57BL/6 female mice aged
15 to 16 and 28 days postpartum (Harlan, Shardlow, United
Kingdom). Mice were housed in accordance with the Animals
(Scientific Procedures) Act of 1986 and associated Codes of
Practice. Ovaries were removed, and those from 28-day-old mice
were fixed in 10% neutral buffered formalin (Sigma Aldrich
Company, Dorset, United Kingdom). Preantral follicles were
mechanically isolated from mice aged 15 to 16 days using acu-
puncture needles, as previously described (22, 23), and placed
in Liebovitz L15 medium (Life Technologies, Paisley, United
Kingdom) supplemented with 1% (weight/volume) bovine serum
albumin (Sigma). Individual follicles were then transferred into
a single well (one follicle per well) in a 96-well plate containing
100 mL Minimal Essential Medium alpha (MEM-a, Life
Technologies) supplemented with 0.1% bovine serum albumin,
75 mg/mL penicillin (Sigma), 100 mg/mL streptomycin sulfate
(Sigma), and a cocktail of 5 mg/mL insulin, 5 mg/mL transferrin,
and 5 ng/mL sodium selenite (Sigma). Isolated follicles from each
ovary were distributed randomly (by picking up from a slightly
out-of-focus drop of culture medium) and evenly between
treatments in a single 96-well plate. Up to six ovaries (plates) were
cultured per experiment. Follicles were incubated in a humidified
incubator in 5% CO2 at 37°C for up to 72 hours.
Analysis of follicle development
Follicles were photographed daily, and follicle area or di-
ameter was measured using ImageJ 1.45s (https://imagej.nih.
gov/ij/) at each time point. At the end of culture period,
follicles were either snap frozen for expression studies or fixed in
formalin for immunofluorescence studies.
During the course of this study, images and growth data on
1307 follicles were acquired. These images, taken at 24-hour
intervals, as well as measurements were imported into a custom-
made database (FileMaker Pro 11.v2; http://www.filemaker.
com). This allowed automatic calculation of cumulative follicle
growth in terms of relative size compared with the start of culture
(time 0) for each follicle, as well as follicle diameter. The database
also facilitated inspection of follicles during development, an-
notation of morphological features, and the implementation of
strict inclusion and exclusion criteria. Follicle images were scored
by one observer in a database layout that lacked information
about treatment. Follicles with a central spherical oocyte and
intact layer of GCs were included in the analysis [Fig. 1(a)].
Follicles were excluded from analysis if, at the start of culture,
their oocyte was misshapen [Fig. 1(b) and 1(g)] or extruded from
the follicle, if the follicle was atretic (darkened GCs) [Fig. 1(e)
and 1(f)], or if the basal laminawas damagedwith the oocyte being
subsequently extruded from the follicle during culture [Fig. 1(c)].
Follicles were also excluded from analysis if they died during
culture, with oocyte extrusion or the onset of atresia [Fig. 1(d)].
The database also expedited search and export of data for
follicles cultured under the same conditions for several further
investigations, providing an extended dataset for analysis of
developmental and morphological features such as antrum
formation or for comparing development of follicles of differing
sizes in various treatments.
Effect of androgens on preantral
follicle development
Isolated follicles were cultured in either control medium or
with androgen (either 10 nM DHT or 10 nM testosterone;
Sigma) in the presence and absence of 20 mM flutamide
(a competitive AR inhibitor; Sigma). DHT, testosterone, and
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flutamide were dissolved in ethanol, and the final concentration
of ethanol in each treatment and in control wells was 0.1%.
Effect of initial follicle size on responsiveness to DHT
Upon completion of all the culture experiments, the data-
base was mined for follicles cultured under control conditions
and in the presence of DHT alone. Follicles were grouped in five
bins according to initial diameter at 0 hours: ,100, 100
to 109.99, 110 to 119.99, 120 to 129.99, and $130 mm in
diameter. The overall growth of follicles in
the presence and absence of DHT was
compared using linear regression (Prism 6
for Mac OS X, version 6.0a; http://www.
graphpad.com).
Effect of DHT on AR expression
Mechanically isolated follicles cultured
for 24 or 72 hours in the presence or ab-
sence of 10 nM DHT were formalin fixed
and set in 2% (weight/volume) low-
melting-point agarose (Sigma) before be-
ing dehydrated through an alcohol series,
embedded in wax, and serially sectioned
(5 mm) onto Superfrost charged slides
(VWR, Lutterworth, United Kingdom).
Immunofluoresence detection of AR was
carried out as described later, and one
central section of each follicle was selected
for analysis. Confocal images of individual
follicles were imported into ImageJ and
split into red-green-blue channels. Blue 40,6-
diamidino-2-phenylindole (DAPI)–labeled
nuclei were thresholded (same threshold
value for all follicles) to produce a binary
image (white DAPI, positive; black DAPI,
negative) and define the nuclei. Nuclei
were outlined using the “Analyze Particles”
command. In the green channel, AR labeling
was thresholded (with the same threshold
maintained for all follicles), the nuclear
outlines were overlaid, and the area of
labeling exceeding the threshold was mea-
sured within the nuclear outlines, and for
the GC layer as a whole. The proportion of
nuclear area or GC area that exceeded the
threshold (i.e., the proportion of the nuclei,
or GC layer, that was AR positive) was
compared for control and DHT-treated
follicles at 24 and 72 hours.
Antrum formation
The database was further used for in-
vestigating antrum formation in the pres-
ence and absence of DHT and under
other treatment conditions. An antrum
was clearly visible as a translucent area
with a clearmargin in the GCs. Images were
inspected and annotated for appearance
of an early antrum by 72 hours of culture.
Effect of androgen and FSH on preantral
follicle growth
Follicles were treated with control medium (including 0.1%
ethanol vehicle) or with 10 nM DHT and/or 10 ng/mL FSH
(recombinant human FSH; National Hormone and Peptide
Program, National Institute of Diabetes and Digestive and
Kidney Diseases, Dr. A.F. Parlow, Torrance, CA). Follicles
were maintained in culture for 24, 48, or 72 hours before being
frozen for gene expression studies as previously described.
Figure 1. Morphology of manually isolated follicles that were included in the analysis (a;
84%) or excluded from analysis because of damage or atresia at the start of culture (b, c, e, f,
and g; ,15%) or onset of atresia during culture (d; ,1%). (a) Healthy follicle cultured under
control conditions (72 hours) with a central oocyte (O) and even layer of GCs. Follicle
diameter shown in each image. The white dotted line (a’’’) indicates the basal lamina
surrounding the GCs and shows the area that is measured. A nucleolus is arrowed (white
arrowhead). Note the lack of theca cells on the basal lamina. (b) Follicle with indistinct oocyte
(white arrow) that becomes increasingly misshapen and shrunken with time. (c) Follicle with
damaged basal lamina (black arrow), resulting in extrusion of GCs (white arrow). With time
in culture, the oocyte is extruded through the breach (black arrow). (d) Follicle that appears
healthy at 0 hours but becomes atretic from 24 hours, with rounding up and progressive
darkening of the GCs and loss of the basal lamina. (e and f) Atretic follicles at the start of
culture (0 hours) with a detached basal lamina (black arrows) and darkened GCs. (g) Follicle
with collapsing, indistinct oocyte (white arrow, 0 hours). (h) Sparse theca cells (black arrows)
on basal lamina. Scale bars = 50 mm (a–g) and 25 mm (h).
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Images of each individually cultured follicle were taken at
0, 24, 48, and 72 hours, as appropriate.
Effect of inhibiting Alk6 on DHT action
Dorsomorphin (DSM; Sigma) was used as an inhibitor of
the type I TGFb receptors ALK2, ALK3, and ALK6 (24).
Follicles were cultured with vehicle alone, 10 nM DHT alone,
DHT and 1 mM DSM (23), and DSM alone for 72 hours.
Follicle growth was assessed as described previously. At the end
of culture, follicles were snap frozen in liquid nitrogen for gene
expression studies, as described later.
Expression studies
At the end of each appropriate culture period, approxi-
mately five follicles per treatment group were pooled into one
tube and snap frozen in liquid nitrogen. Samples were then
processed for RNA extraction using RNeasy microcolumns as
per manufacturer’s instructions (Qiagen, Manchester, United
Kingdom). The resulting RNA was concentrated using vacuum
centrifugation to provide a final volume of approximately 5 mL
and converted to complementary DNA (cDNA) using Super-
Script III reverse transcription and random hexamers, according
to manufacturer’s instructions (Life Technologies). cDNA
productswere used for quantitative polymerase chain reaction as
previously described (23). Briefly, primers were designed using
Primer3 plus v2.3.6 software (Table 1). cDNAorwater (control)
was added to a reaction mix that included 500 nM of appro-
priate primers (ROX, KAPA SYBR FAST; KAPA Biosystems
Limited, London, United Kingdom) and nuclease-free water.
Each sample or control mix was plated in duplicate, and am-
plificationwas carried out using anApplied Biosystems 7900HT
Fast instrument. A melt curve analysis was carried out on each
sample. Atp5b (Primer Design, Southampton, United Kingdom)
was determined to be an appropriate internal reference gene and
therefore used in this series of studies. Expression levels were
normalized to the internal reference gene and calculated as
fold changes relative to the untreated control group, using the
2-delta-delta-cycle threshold method (25).
Immunofluorescence studies
Whole formalin-fixed, paraffin-embedded ovaries were se-
rially sectioned (5 mm) to examine AR protein expression. For
examination of the effect of treatment on AR protein expres-
sion, cell proliferation, and apoptosis, formalin-fixed, cultured
follicles were set in 2% (weight/volume) low-melting-point
agarose (Sigma) before being dehydrated through an alcohol
series, embedded in wax, and serially sectioned (5 mm) onto
Superfrost charged slides (VWR, Lutterworth, United King-
dom). Ovary and follicle sections were dewaxed and rehydrated
prior to boiling in citrate buffer (10 mM citric acid, pH 6.0) and
blocking of nonspecific binding within 20% normal goat se-
rum (Sigma). After this, with no washing step, sections were
incubated in rabbit anti-mouse AR antibody NR-20 (sc-816,
1:200 dilution; Santa Cruz, Dallas, TX), rabbit anti-mouse
D3B5 Ki67 (1:200; New England Biolabs, Hitchin, United
Kingdom), or rabbit anti-mouse cleaved caspase-3 (1:200; 9664,
Cell Signaling) diluted in 2% normal goat serum (Table 2). The
latter were subsequently exposed to a 1:9 ratio of terminal
deoxynucleotidyltransferase-mediated dUTP nick end labeling
(TUNEL) enzyme:label (Roche) for 60 minutes at 37°C after
phosphate-buffered saline washes. The negative control for
AR immunofluorescence was rabbit immunoglobulin G (Sigma
i8140) at the same concentration as that used for the primary
antibody (0.5 mg/mL). The primary antibodies were incubated
overnight at 4°C and then detected using an appropriate goat anti-
rabbit Alexafluor secondary antibody (1:500; Life Technologies).
Table 1. Primers Used for Quantitative Polymerase Chain Reaction Assays
Gene Symbol Primer Sequence (50-30) GenBank Accession Product Size (bp)
Amh Fwd: ggggcacacagaacctct NM_007445.2 124
Rev: gcaccttctctgcttggttg
Bmp15 Fwd: gagaaccgcacgattggag NM_009757.4 134
Rev: agttcgtatgctacctggtttg
Gdf9 Fwd: tcacctctacaataccgtccgg NM_008110.2 139
Rev: gagcaagtgttccatggcagtc
Fshr Fwd: acaactgtgcattcaacggaac NM_013523.3 187
Rev: gacctggccctcaacttctt
Ar Fwd: attctggatgggactgatg NM_013476.4 246
Rev: gcccatccactggaataatg
Star Fwd: aagaacaacccttgagcacct NM_011485.4 267
Rev: ctccctgctggatgtaggac
Cyp11a1 Fwd: ctgggcactttggagtcagt NM_019779.3 185
Rev: aggacgattcggtctttcttc
Amhr2 Fwd: acagcatgaccatatcgttcg NM_144547.2 122
Rev: gagtcaagtagtggcataaggag
Bmpr2 Fwd: actgggaggtgtttatgaggtg NM_007561.4 150
Rev: ggaacttgggtctctgcttct
Alk3 (Bmpr1a) Fwd: tgactttagcaccagaggatacc NM_009758.4 177
Rev: cagagccttcatacttcatacacc
Alk4 (Acvr1b) Fwd: caacatgaagcactttgactcc NM_007395.3 177
Rev: tcacatacaacctttcgcatct
Alk5 (Tgfbr1) Fwd: attgctccaaaccacagagtag NM_009370.3 157
Rev: caccaatagaacagcgtcgag
Alk6 (Bmpr1b) Fwd: aggaggatggagagagtacagc NM_007560.4 166
Rev: ccagaggtgacaacaggcatt
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All unstained nuclei were then visualized by incubationwithDAPI
(1:1000; Life Technologies) before sections were mounted under
coverslips using Prolong Gold mounting medium containing DAPI
(Life Technologies). Sections were visualized (363 objective) and
captured using a Leica inverted SP5 confocal laser-scanning micro-
scope (Leica Microsystems, Cambridge, United Kingdom).
Ki67-positive, caspase-positive, TUNEL-positive, and unlabeled
DAPI-stained cells or nuclei were counted using the ImageJ plugin
“cell counter.jar” (https://imagej.nih.gov/ij/plugins/cell-counter.html)
within ImageJ (1.45s). DAPI-labeled (blue), Ki67-positive (green),
and TUNEL-positive (green) nuclei or caspase-positive (red) cells
were counted in a singlemidsectionof the follicle, and theproportion
of Ki67-positive, caspase-positive, or TUNEL-positive nuclei/cells
was calculated.
Statistics
The relative area of follicles in different treatments (area at
timex/area at time0, where timex = 24, 48, or 72) was compared at
each timepoint usingone-wayanalysis of variance (ANOVA)with
the appropriate post hoc test for multiple comparisons (Prism 6).
Gene expression values were log2 transformed, and the difference
between treatments was analyzed using a t test. In all cases, a
P value less than 0.05 was considered statistically significant.
Results
Follicle culture
In this study, a total of 1307 follicles from 45 ovaries
were cultured in various conditions. On average, 296 0.68
follicles (mean and standard error of the mean [SEM]; range
22 to 40) per ovary were cultured and evenly distributed
between treatments. Overall, less than 15% of follicles
placed in culture were found, upon closer high-power in-
spection, to be either atretic or damaged at the outset (Fig. 1)
and were therefore excluded from further analysis. A very
small number of follicles (12) died during culture: four con-
trols, three cultured inDHT alone and five inDHTplus FSH.
Effect of androgens on preantral follicle growth
DHT at doses of between 1 and 100 nM resulted in an
increase in follicle growth compared with vehicle alone at
24, 48, and 72 hours in culture [Fig. 2(a)]. Although the
largest response was achieved with a dose of 100 nM,
there was little difference between the effects of the dif-
ferent doses. A similar dose-response range was found for
the effects of testosterone on follicle growth (data not
shown). In all subsequent studies, a dose of 10 nM DHT
or testosterone (approximating to physiological serum
concentrations of testosterone) was therefore used.
Flutamide inhibited DHT-induced follicle growth in a
dose-dependent manner [Fig. 2(b)], but as the effect was
significant only at a flutamide concentration of 20 mM,
this dose was used in further studies
The effects of DHT (a nonaromatizable androgen) and
testosterone (an aromatizable androgen) were compared.
Both androgens significantly increased follicle growth over
72 hours in culture [Fig. 2(c)]. At all time points, DHT and
testosterone did not significantly differ in their stimulatory
effect on follicle growth. The addition of flutamide to
androgen-treated follicles inhibited the effect of both andro-
gens and brought follicle growth back in line with controls.
We were interested in whether the responsiveness of
preantral follicles to DHT changed with follicle size.
Taking an overview of all the data that we collated in the
database during these studies, we explored how DHT
affected the growth of follicles of different sizes. Isolated
follicles placed in culture ranged in size from 75 to
150 mm in diameter. Intriguingly, although smaller fol-
licles grew significantly more in the presence of DHT,
there was no significant increase in the growth of larger
follicles (.130 mm) with DHT. This suggests that these
follicles have become less androgen responsive [Fig. 2(d)].
Expression of AR in whole mouse ovary and in
cultured follicles
Immunofluorescence for AR showed expression in
follicles from the primordial stage onwards in day 17
ovary [Fig. 3(a)]. In primordial and transitional follicles,
AR appeared to be expressed in the ooplasm more
Table 2. Antibody Table
Peptide/
Protein
Target Antigen Sequence Name of Antibody
Manufacturer,
Catalog No.,
RRID No.
Species Raised in
Monoclonal or
Polyclonal
Dilution
Used RRID
Androgen
receptor
Epitope mapping at N
terminus
AR (N-20) Santa Cruz
Biotechnology,
sc-816
Rabbit, polyclonal 1 in 200 AB_1563391
Ki67 Recombinant protein
specific to the amino
terminus of Ki-67
protein
Ki-67 (D3B5; mouse
preferred;
immunohistochemistry
formulated)
Cell Signaling
Technology, 12202
Rabbit, monoclonal 1 in 200 AB_2620142
Cleaved
caspase-3
Large fragment (17/19
kDa) resulting from
cleavage adjacent to
Asp175
Cleaved caspase-3
(Asp175; 5A1E)
Cell Signaling
Technology, 9664
Rabbit, monoclonal 1 in 200 AB_2070042
Abbreviation: RRID, Research Resource Identifier.
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strongly than at later stages, and even in very early fol-
licles, AR was clearly present in GCs [Fig. 3(c)].
Immunofluorescence labeling of AR in follicles cul-
tured in the presence and absence of DHT for 24 and
72 hours was quantified in the GC layer, as well as spe-
cifically in the nuclei [Fig. 3(d–m)]. DHT treatment resulted
in significantly increased expression of AR in the GCs
following 24 hours [Fig. 3(n)] and 72 hours [Fig. 3(p)] of
Figure 2. Follicle growth in vitro in response to DHT and testosterone. (a) Response of individual follicles to increasing concentrations of DHT. The
relative area of follicles in different treatments (area at timex/area at time0, where timex = 24, 48, or 72) was compared at each time point using one-way
ANOVA with a Tukey’s multiple comparisons test. *P , 0.05, ***P , 0.001, ****P , 0.0001. Values are mean and 95% confidence interval. Numbers
in parentheses are numbers of follicles. (b) Response of follicles to DHT (10 nM) in the presence of increasing doses of the AR inhibitor flutamide (Flut).
Values are mean and 95% confidence interval. Statistical analysis as in a. *P , 0.05, **P , 0.01, ****P , 00001. (c) Response of follicles to DHT
(10 nM) or testosterone (10 nM) in the absence and presence of flutamide (20 mM). DHT- and T-stimulated follicle growth was reversed by flutamide.
Values are mean and 95% confidence interval. Statistical analysis as in a. *P , 0.05, **P , 0.01, ***P , 0.001, ****P , 00001. (d) Effect of DHT on
in vitro growth of follicles of different initial sizes. Values are means and standard deviation, and lines are regression slopes. Slopes were compared using
linear regression. Follicles larger than 130 mm in diameter at the start of culture did not grow more in the presence of DHT. Con, control.
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Figure 3. AR is present in oocytes, GCs, and theca cells of preantral follicles, and overall expression and nuclear localization of AR increases in
the presence of DHT. (a) AR expression (green) in mouse prepubertal mouse ovary on day 17 postpartum. DAPI-labeled nuclei are blue. Scale bar =
50 mm. White dotted lines indicate basal lamina surrounding follicles. (b) Rabbit immunoglobulin G control. Scale bar = 25 mm. (c) Strong labeling
of ooplasm (white arrow) and GC cytoplasm (white arrowhead) in primordial and transitional follicles. Scale bar is 25 mm. (d–m) Quantification of
AR in formalin-fixed, paraffin-embedded sections of follicles cultured in the absence (d–h) and presence (i–m) of DHT. (d and i) Confocal image of
follicle showing expression of AR (green) and DAPI-labeled nuclei (blue). Scale bars = 25 mm. White dotted box defines enlarged images (e–h and
j–m). Images were imported into ImageJ and split into red-green-blue channels. Blue DAPI-labeled nuclei (e and j) were thresholded (f and k; where
white is DAPI positive and black DAPI negative), and nuclei were outlined using the “Analyze Particles” command (f and k). In the green channel,
AR labeling (g and l) was thresholded (with the same threshold maintained for all follicles), the nuclear outlines were overlaid, and the area of
labeling exceeding the threshold was measured within the nuclear outlines (h and m), and for the GC layer as a whole. Yellow arrows (h) indicate
nuclei with little nuclear AR, and yellow arrowheads (m) indicate nuclei with strong nuclear AR. White arrowheads (l and m) show strong AR
expression in theca cell nuclei. Values were plotted and compared between treatments using a Mann-Whitney test. Overall AR protein expression in
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culture. Furthermore, translocation of AR to the nu-
cleus was minimal in control follicles [Fig. 3(h)] but
was significantly increased in follicles exposed to DHT at
both time points [Fig. 3(m), 3(o), and 3(q)]. Strong labeling
of theca cell nuclei for AR was also observed following
DHT treatment [Fig. 3(l) and 3(m), white arrows].
DHT and antrum formation
Examination of 219 follicles cultured under control
conditions and 216 follicles cultured with DHT alone
that were identified from the database showed that sig-
nificantly (P , 0.0001) more follicles cultured in DHT
developedanantrumduring72hours of culture [Fig. 4(a–g)].
We expected that this would be due to the increased follicle
growth observed in the presence of DHT and that antra
would be seen in the largest follicles. Surprisingly, we found
that there was no significant difference in diameter between
follicles with andwithout an antrum in the presence of DHT
[Fig. 4(h)], suggesting that this developmental change is not
due to accelerated growth but to another, as yet unknown,
mechanism.
The stimulatory action of DHT on follicle growth was
accompanied by increased protein expression of the pro-
liferation marker Ki67 in GCs of preantral follicles fol-
lowing both 24 and 72 hours of culture [Fig. 5(a–d)].
Follicles were assessed after 24 and 72 hours of culture for
evidence of apoptosis using dual labeling for TUNEL [Fig.
5(e) and5(f)] and active caspase-3 [Fig. 5(g) and5(h)]. There
was no significant difference between control and DHT-
treated follicles in the incidence of these apoptoticmarkers.
Generally, apoptosis was observed in a small proportion
ofGCsat 24hours [Fig. 5(i) and5(j)] and72hours [Fig. 5(m)
and 5(n)], with the exception of a few follicles showingmore
widespread TUNEL labeling [Fig. 5(k) and 5(l)].
Interaction of DHT with FSH
FSH (10 ng/mL) significantly increased the proportionate
growth of cultured preantral follicles compared with con-
trol.WhenDHTwas added to the cultures, the combination
of DHT and FSH increased follicle growth in comparison
with either individual treatment alone after 24 hours and,
particularly, after 48 and 72 hours in culture [Fig. 6(a)].
Interestingly, we observed that, after 72 hours in culture
with the combined treatment of DHT and FSH (but not
with the individual treatments alone), the basal lamina
surrounding theGC layers in some follicles was disrupted,
allowing extrusion of some GCs vertically as well as
horizontally, and thereby possibly decreasing the pre-
cision of follicle measurement.
Overall, the rate of growth of follicles in the presence
of both DHT and FSH was significantly greater than
that in either treatment alone. Furthermore, follicles in
treatments alone or in combination grew at a signifi-
cantly faster rate than control follicles [Fig. 6(b)]. The
dose of FSH used here was the lowest dose that elicited a
maximal response in a previous study (26). We were
interested to explorewhether the presence of DHTwould
allow a lower dose of FSH to stimulate the samemaximal
response. This was not the case; lower doses of FSH
resulted in minimal growth [Fig. 6(c)].
Effects of androgens and FSH on gene expression
FSH receptor, steroid synthesis, and action
FSH receptor (Fshr) expression was significantly in-
creased in follicles cultured in DHT compared with
vehicle-treated controls after 24 hours in culture, whereas
FSH treatment reduced expression of Fshr. This effect
was partially reversed during cotreatment with DHT
[Fig. 6(d)]. DHT alone had a small and insignificant
effect on expression of Star but further enhanced FSH-
stimulated Star expression.
We examined the time course of gene expression of
androgen receptor (Ar), Fshr, Star,Cyp11a1,Cyp17, and
Cyp19 during 72 hours of culture in presence of DHT
(Fig. 7). AR expression was consistently suppressed by
DHT, whereas that of Fshr was increased at each time
point. Expression of Star was significantly up-regulated
after 72 hours in culture, whereas that of Cyp11a1 was
significantly reduced after 48 hours in culture and further
reduced at 72 hours (Fig. 7). Cyp19 expression was
undetectable, as was that of Cyp17.
Effect of DHT and testosterone on TGFb ligands
and receptors
In this series of studies, we examined the effects of
either DHT or testosterone on gene expression after
24 hours in culture (Fig. 8). Expression ofArwas reduced
and that of Fshr increased by DHT, as shown previously;
similar changes were seen in response to testosterone.
We observed a significant interaction of androgens
with ligands and receptors of the TGFb superfamily in
these studies (Fig. 8). Exposure to androgens during
culture resulted in reduction of expression of Amh and
Bmp15 by both DHT and testosterone. A similar trend
was observed for Gdf9, but the change was not signifi-
cant in response to DHT. Testosterone, but not DHT,
reduced expression of Amhr2, and both androgens
reduced Bmpr2 expression. Expression of the type 1
Figure 3. (Continued). the GC layer was significantly increased after 24 hours (n) and 72 hours (p) culture in the presence of DHT. Nuclear
localization of AR was also significantly increased in the presence of DHT at 24 hours (o) and 72 hours (q). 1°+, primary stage with second layer
of GCs appearing; 2°, secondary stage; e1°, early primary; ose, ovarian surface epithelium; p, primordial; T, theca; t, transitional.
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receptorsAlk3,Alk4, andAlk5were similarly reduced
by both androgens, but, again, only the actions of tes-
tosterone were significant. However, both DHT and
testosterone stimulated expression ofAlk6. All androgen-
induced changes in gene expression were negated by
coincubation with flutamide (data not shown).
To explore the functional significance of androgen-
induced changes in gene expression of TGFb ligands and
their receptors, we examined the effects of the Alk2/3/6
inhibitor DSM (24) [Fig. 9(a)] on follicle growth and
gene expression in the presence and absence of DHT. As
shown in our previous study (23), DSM alone stimulated
follicle growth at 24 hours (P, 0.05), but here we show
that the response to DHT was significantly enhanced by
the addition of DSM [Fig. 9(b)]. DSM did not, however,
influence DHT-dependent antrum formation.
DSM alone resulted in reduction in expression ofAmh
after 72 hours in culture but with no significant effect on
Gdf9 [Fig. 9(c)]. However, DSM further enhanced the
inhibitory effect of DHT on Amh without influencing
DHT-induced Gdf9 expression. Neither DSM alone nor
DSM with DHT had an effect on expression of Bmp15.
DSM alone had no effect on Amhr2 but led to increased
expression of Alk5 and, as anticipated, reduction in Alk6
[Fig. 9(e)]. The addition of DHT resulted in greater
production ofAmhr2 than either DSMorDHT alone and
reversed the effects of DSM on Alk5 and Alk6 [Fig. 9(e)].
There was no significant effect of DSM alone on Ar or
Fshr, and DSM did not affect the response to DHT
[Fig. 9(d)]. However, DSM alone enhanced expression of
Star and further increased DHT-stimulated expression
[Fig. 9(f)]. Interestingly, DSM alone led to an increase in
Cyp11a1 and reversed the inhibitory response to DHT
[Fig. 9(f)].
Discussion
The purpose of these studies was to examine the role of
androgens in preantral follicle development to provide
insight into the mechanism of aberrant early follicle de-
velopment in human PCOS. Exposure to excess androgen
has been postulated to underpin the probable develop-
mental origin of PCOS and its adult manifestations of
reproductive and metabolic dysfunction (14, 27, 28).
Using a mouse model of preantral follicle development
that has been well validated in our laboratory, we have
shown that exposure to both DHT and testosterone
Figure 4. Follicles cultured in the presence of DHT had a 10-fold
increased incidence of early antrum formation. (a) The number of follicles
in the absence and presence of DHT that formed an antrum by 72 hours
of culture. Numbers above the bars are the percentage of follicles that
formed an antrum (P , 0.0001; two-sided Fisher’s exact test. (b-–f)
Examples of preantral follicles with an antrum (arrowed, translucent area
within the GCs) cultured in DHT. (g) Confocal image of DHT-treated
follicle exposed to DHT in vitro with oocyte (ooc) and antrum arrowed.
(h) Diameter of follicles at 48 hours (i.e., at the onset of possible antrum
formation) that did, or did not, have an antrum at 72 hours. Four
statistical comparisons were made (to compare diameter of follicles with
Figure 4. (Continued). and without antra within a treatment; and of
follicles with, or without, antra between treatments) using one-way
ANOVA with a Sidak’s multiple comparison test. ***P , 0.001. ns, not
significant.
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have a plethora of effects on both follicle growth and
gene expression of key molecules implicated in follicle
function. As shown in previous studies of cultured isolated
follicles from mouse ovary (1, 9), androgens stimulate
follicle growth. This effect is mirrored in studies of
prentral follicle development in the primate ovary fol-
lowing in vivo androgen treatment (29, 30). In addition to
the increase of follicle diameter in response to androgens,
our results show a significant increase in expression of
the proliferation marker Ki67, whereas the expression of
proapoptotic markers TUNEL and caspase was no dif-
ferent between treated and untreated follicles. Further-
more, there was a 10-fold increase of antrum formation,
an index of accelerated growth, in the presence of DHT.
Thus, although androgens have been shown to have
proapoptotic effects in GCs of large antral follicles
(10, 11), the predominant action of testosterone and
DHT in preantral follicles appears to be stimulation of
GC proliferation and net follicle growth.
In sections of juvenile mouse ovary, we found that AR
was expressed in the cytoplasm of oocytes, GCs, and
theca at all preantral stages, including primordial folli-
cles. DHT treatment increased the overall expression
of AR in cultured follicles and, importantly, increased
nuclear localization of AR, as would be expected in re-
lation to androgen-induced growth and differentiation.
Increased expression of AR protein was interesting and
paradoxical, as we have also demonstrated here that Ar
messenger RNA is decreased by DHT treatment during
culture.
With the exception of the specific experiment ex-
ploring the effect of DHT in the presence of FSH, all the
follicles in this study were cultured without FSH. Use of
the database allowed examination of the response of
Figure 5. Follicles cultured in the presence of DHT had a greater proportion of Ki67-positive (green) nuclei than in control conditions after
24 hours (a) and 72 hours (b) of culture. Bars are means and 95% confidence interval; treatments were compared using an unpaired t test.
**P , 0.01. (c and d) Confocal images of Ki-67–positive nuclei (green); scale bars = 50 mm. (e–h) There was no significant effect of treatment
on TUNEL (e and f, green) and caspase (g and h, red) expression in control and DHT-treated follicles at 24 and 72 hours. Bars are medians;
treatments were compared using a Mann-Whitney test. (i–g) Confocal images of TUNEL-labeled (green) and active caspase-positive GCs (red) in
follicles at 24 hours (i and j) and 72 hours (k–n) cultured in the absence (i, k, and m) and presence (j, l, and n) of DHT. Nuclei were
counterstained with DAPI (blue). Scale bars = 25 mm (i–n).
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follicles of increasing size to DHT alone. Small follicles
less than 130mm in diameter grewmore in the presence of
DHT. This is in contrast to our observations of the effects
of FSH on preantral follicle growth in culture, in that
responsiveness to added FSH was greatest in follicles
larger than 130 mm in diameter (26), leading us to
conclude that follicles larger than 130 mm in diameter
had a greater requirement for FSH. It may be that the
lack of response to DHT in larger follicles in the current
study is due to the need for FSH to grow in vitro.
An important observation is the positive interaction
with FSH in terms of both follicle growth and gene ex-
pression. Both FSH, as previously shown (26), and DHT,
independently, stimulated growth of preantral follicles in
culture, but FSH increased the responsiveness to DHT
in a dose-dependent manner. After 72 hours in culture,
the optimum dose of FSH induced a 30% increase in
follicle growth above that of DHT alone. The amplifying
effect of androgens on FSH-stimulated steroidogenesis
was described more than 20 years ago by Wang and
Greenwald (4), and recently Sen and colleagues have
shown that DHT has both antiapoptotic and proproli-
ferative effects, the latter being mediated, at least in part,
by increased FSH receptor expression (31). Here we
confirm the effects of DHT on FSH receptor gene ex-
pression and, in addition, show that testosterone has a
similar effect. It is not clear whether the increase in the
expression of Fshr is due to increased expression per cell
Figure 6. (a) FSH further stimulates DHT-stimulated follicle growth after 48 hours of culture. Relative area of follicles in different treatments was
compared at each time point using one-way ANOVA with a Tukey’s multiple comparisons test. *P , 0.05, **P , 0.01, ***P , 0.001,
****P , 00001. Values are mean and 95% confidence interval. Numbers in parentheses are numbers of follicles. (b) Growth trajectory over time
of follicles cultured in the absence and presence of DHT and/or FSH. A combination of DHT and FSH stimulates a greater rate of growth than
DHT alone (P , 0.0001), FSH alone (P , 0.0001), or control (P , 0.0001). FSH or DHT alone stimulates a greater rate of growth than control
(FSH, P , 0.0001; DHT, P , 0.002). The rate of growth in FSH alone is significantly greater than that in DHT alone (P , 0.0004). Values are
means and SEM, and lines are regression slopes. Slopes were compared using linear regression. Numbers in parentheses are numbers of follicles.
(c) Follicles cultured in the presence of DHT and increasing doses of FSH showed significant growth enhancement in the presence of 1 ng/mL and
10 ng/mL FSH, but not in the lowest dose of FSH (0.1 ng/mL). Statistical comparisons as in a. (d) Change in expression of Fshr and Star in four
samples of five follicles, each cultured for 24 hours in the presence of DHT alone, FSH alone, or DHT and FSH in combination. Data have been
log2 transformed, and treatments were compared with control (0) and between treatments using an unpaired t test. Fold change indicated in
right-hand y axis. Asterisks by error bars indicate a significant difference in expression from control; differences between treatments are indicated
by asterisks on horizontal lines. P values as in a. Values are mean and SEM.
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or to the increased number of cells in follicles cultured in
the presence of androgens (or indeed both). The action of
both androgens was reversed by the AR antagonist flu-
tamide, indicating that the effect of testosterone was not
likely to be attributable to its possible conversion to es-
tradiol. The most significant effect of androgens on the
steroidogenic pathway was an increase in expression of
Star, which, of course, has a key role in making cho-
lesterol available for steroid synthesis. Both DHT and
FSH independently and interactively increased Star ex-
pression. Conversely, expression of Cyp11a1 was sup-
pressed by exposure to androgens, but these findings are
in accord with observations in studies of the ovaries of
day 90 fetal sheep whose mothers were treated with
testosterone (18)
Very little has been reported to date on the interaction
of androgens and the TGFb family of growth factors.
There are isolated reports that TGFb1 inhibits androgen
production by theca cells (32, 33), but, as far as we are
aware, there have been no systematic studies of the effects
of androgens on TGFb signaling. Our group has pre-
viously reported on expression and action of TGFb
growth factors in isolated mouse preantral follicles (22,
23), and in the current study, we examined the interaction
of androgen with TGFb ligands and their receptors. The
most significant findings were inhibition by androgens
ofAmh andBmp15 expression.AMHhas awell-described
inhibitory action of preantral follicle growth (34), and
BMP15 has a biphasic effect, initially stimulating growth
but then leading to reduced growth rate and apoptosis in
mouse preantral follicles after 48 hours in culture (23). In
our studies, AMH expression was progressively reduced
with time of exposure to androgens. Studies in sheep
support this observation, as AMH protein expression is
lower in large preantral follicles in 10- and 21-month-old
prenatally testosterone-treated ewes compared with un-
treated controls (35). AMH and BMP15 activate receptor
heterodimers that comprise the type 2 receptors AMHR2
andBMPR2, respectively, and the type1 receptorAlk6 that
is used by both ligands. Androgen-stimulated follicle
growth is accompanied by reduced expression not only of
Amh and Bmp15, but also of Amhr2 and Bmpr2. In
addition, DSM, an inhibitor of Alk2/3/6, amplified DHT-
stimulated follicle growth and further reduced expression
of Amh. Taken together, these findings support the view
that attenuation of the inhibitory effects of AMH and
BMP15 play a role in the mechanism of androgen stim-
ulation of preantral follicle development. There were also
significant effects of DSMon the steroidogenic pathway in
that, along with enhanced follicle growth, DSM amplified
expression of key molecules involved early in the ovarian
steroidogenic pathway (Star and Cyp11a) and modified
the effects of DHT. This suggests a functional cross-talk
Figure 7. Time course of hormone receptor and steroidogenic
enzyme gene expression in isolated follicles during 72 hours of
culture in the presence of DHT. Change in expression of Ar, Fshr1,
Star, and Cyp11a1 in four to six samples of five follicles, each
cultured for 24, 48, and 72 hours in the presence of 10 nM DHT.
Data have been log2 transformed, and DHT treatment was
compared with time-matched control samples (0) and between time
points using an unpaired t test. Fold change is indicated in right-
hand y axis. Asterisks by error bars indicate significant difference in
expression from control, and differences between time points are
indicated by asterisks on horizontal lines. *P , 0.05, **P , 0.01,
***P , 0.001, ****P , 00001. Values are mean and SEM.
Figure 8. Effect of DHT (a) and testosterone (b) on gene expression
of hormone receptors and members of the TGFb superfamily
(ligands and receptors). Isolated follicles were cultured in the
presence and absence of DHT or testosterone for 24 hours. Data
have been log2 transformed, and DHT or testosterone treatment
was compared with control samples (0) using an unpaired t test.
Fold change is indicated on right-hand y axis. Asterisks by error bars
indicate significant difference in expression from control. *P , 0.05,
**P , 0.01, ***P , 0.001. Values are mean and SEM.
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BMPR2 ALK6
DSM
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(e)
(b)
Treatment (72h)
Figure 9. Effect of DSM (an inhibitor of Alk2, 3, and 6) on DHT-stimulated follicle growth in vitro for 72 hours. (a) TGFb receptor inhibition by
DSM. (b) Isolated follicle growth in the presence and absence of DHT and/or DSM. Relative area of follicles in different treatments was compared
at each time point using one-way ANOVA with a Tukey’s multiple comparisons test. *P , 0.05, **P , 0.01, ***P , 0.001, ****P , 00001.
Values are mean and 95% confidence interval. Numbers in parentheses are numbers of follicles. (c–f) Effect of DHT alone, DSM alone, and DHT
in combination with DSM on gene expression following 72 hours of culture. Data have been log2 transformed, and DHT, DSM, or DHT plus DSM
treatment was compared with control samples (0) using an unpaired t test. Fold change is indicated in right-hand y axis. Asterisks by error bars
indicate significant difference in expression from control, and differences between treatments are indicated by asterisks on horizontal lines.
*P , 0.05, **P , 0.01, ***P , 0.001, ****P , 00001. Values are mean and SEM. (c) TGFb ligands. (d) Hormone receptors. (e) TGFb
receptors. (f) Steroidogenic enzymes.
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between the TGFb system and the classic steroidogenic
pathways. DSM has previously been described as an
inhibitor of adenosine 50-monophosphate kinase, but
although we cannot rule out the possibility that this
mechanism may play a part in the observed effects on
follicle growth, its high selectivity for the BMP signaling
pathway (24) makes the latter a more plausible target.
In addressing the issue of cross-talk between these
pathways, one of the key findings in the current study
was that, at 24 hours in culture, DHT treatment resulted
in decreased expression of the oocyte-specific gene
Bmp15 (as well as decreased expression of Amh and
Amhr2). These changes were accompanied by increased
expression of Star and down-regulation of Cyp11a. In
this context, it is striking that direct treatment of human
granulosa lutein cells and ovine GCs with rhBMP15
results in opposite effects: increased AMH, AMHR2,
and CYP11A and decreased STAR (19, 36, 37). This
strongly suggests that BMP15 is amajor regulator of both
the rate-limiting steps of steroidogenesis and of AMHand
its receptor and furthermore that DHT is having indirect
actions on these genes via the consequent decreased
levels of this oocyte-derived growth factor. Indeed, the
important role of the oocyte in stimulating AMH ex-
pression was first proposed in 2004 in elegant studies
using cocultures of isolated oocytes and preantral GCs
from mice (38). The presence of one or more oocytes in
the immediate vicinity of GCs increased AMH expression
more than twofold. Furthermore, studies in our labora-
tory comparing AMH expression in intact preantral
Figure 10. Putative pathways of androgen action on preantral follicle growth. Testosterone (T) or DHT act via the AR, causing a measurable
increase in GC proliferation. This may be mediated directly, or indirectly, by increased FSHR (stimulating GC proliferation) or decreased AMH
(reducing AMH inhibition). AMH can be further reduced by androgen-induced reduction of oocyte-specific BMP, which normally stimulates AMH
levels. Inset box summarizes androgen-induced inhibition of TGFb ligands and type I and II TGFb receptors, with the exception of Alk6.
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follicles and follicles lacking an oocyte have shown that
the absence of an oocyte results in almost complete loss of
AMH expression after 24 hours of culture (Mora and
Fenwick, unpublished data). Thus, the effect of DHT (or
testosterone) on follicle growth appears to involve a
complex interaction with both FSH and the intraovarian
TGFb system (Fig. 10). These androgens have a direct
stimulatory effect on growth and also increase FSH re-
sponsiveness by up-regulation of FSH receptor expression.
In addition, DHT and testosterone reduce expression of
AMHboth directly and by inhibition of the oocyte-derived
TGFb growth factor BMP15. BMP15 has been shown to
stimulate AMH production by GCs (and reduce expres-
sion of the growth-promoting GDF9 by the oocyte), hence
reduction of BMP15 levels will contribute to reduced
AMH levels. The net effect of androgens is therefore to
contribute to GC proliferation by reversing the action of
inhibitory TGFb growth factors that are produced by the
oocyte and surrounding GCs. The current study has ex-
amined gene expression of these key ovarian factors, and
it should, of course, be acknowledged that the changes
observeddonot necessarily imply similar effects on protein
expression (as illustrated in this study with regard to AR
gene and protein expression). Nevertheless, where we see
evidence of functional changes (e.g., androgen-dependent
amplification of both Fshr gene expression in parallel with
increased follicle growth rate), the association between
gene and protein expression can easily be implied.
An intriguing effect of DHT on preantral follicle de-
velopment was the precocious formation of an antrum, a
feature that has also been reported in studies of PA sheep
(39). Initially it was thought to be due to the stimulatory
effects of DHT on follicle growth, with the expectation
that antra would be present in the largest follicles.
However, we found that there was no difference in the
diameter of follicles with and without antra, suggesting
that their appearance was due to effects of androgen
on the expression of key genes, rather than achievement
of a threshold diameter. Aquaporins facilitate water
transport and are expressed in GCs (40), and testosterone
stimulated the swelling of porcine GCs in hypotonic
culture medium, an effect that was reversed by flutamide,
suggesting that aquaporins are sensitive to androgen (41).
A recent study by the same group confirmed that follicles
from pigs that were exposed to flutamide in utero
expressed less Aqp5 messenger RNA and protein, dem-
onstrating that androgen could potentially stimulate
aquaporin expression leading to antrum formation (42).
Aberrant ovarian function associated with PCOS and
hyperandrogenism has been well documented, and it has
been suggested that “programming” of ovarian function
by androgens plays a key part (27). This notion is sup-
ported by the results of studies of both rodent and large
animal (sheep and monkey) models of PCOS that in-
volve in vivo exposure to excess androgen (7, 19, 28, 43).
Here, in an ex vivo model, we have examined the direct
effects of androgens on follicle growth and gene ex-
pression and have uncovered pathways that are relevant
to the abnormalities of follicle development that are
characteristic of PCOS (14). The enhancement of FSH-
activated follicle growthmaywell have a bearing not only
on the accelerated growth of preantral follicles, but also
on the precocious responsiveness to luteinizing hormone
that has been observed in small antral follicles in ovaries
of women with PCOS (14, 44). Intriguingly, androgen
action also implicates the participation of key members
of the TGFb superfamily and its receptors, and there
is little doubt that these growth factors have a funda-
mental role in activation andmaintenance of early follicle
development.
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